Nurix Therapeutics, Inc.
US ˙ NasdaqGM ˙ US67080M1036

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Group L P Column. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Group L P Column har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:NGM / NGM Biopharmaceuticals, Inc. Director, 10% Owner 1.000
US:NRIX / Nurix Therapeutics, Inc. 10% Owner 48.406
10% Owner 99.155
US:IMDZ / Immune Design Corp. 10% Owner 0
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Group L P Column. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb NRIX / Nurix Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NRIX / Nurix Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Insidersalg NRIX / Nurix Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NRIX / Nurix Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Group L P Column som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
J - Other 1.000 1.000
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -44.000 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -15.000 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -100.000 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -100.000 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1.298.908 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -1.298.908 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2.265.758 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -968.990 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -858.035 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -11.103.333 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -90.442 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -2.650.177 0 -100,00
2024-04-08 2024-04-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
D - Sale to Issuer -949.862 0 -100,00
2023-11-17 2023-11-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.840 949.862 0,62 0,62 3.627 589.959
2023-11-17 2023-11-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16.791 944.022 1,81 0,71 11.880 667.896
2023-11-17 2023-11-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.840 949.862 0,62 0,62 3.627 589.959
2023-11-17 2023-11-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16.791 944.022 1,81 0,71 11.880 667.896
2023-11-17 2023-11-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.840 949.862 0,62 0,62 3.627 589.959
2023-11-17 2023-11-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16.791 944.022 1,81 0,71 11.880 667.896
2023-02-01 2023-01-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 176.730 927.231 23,55 5,00 883.403 4.634.857
2023-02-01 2023-01-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.542 750.501 1,02 5,00 37.707 3.752.205
2023-02-01 2023-01-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 176.730 927.231 23,55 5,00 883.403 4.634.857
2023-02-01 2023-01-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.542 750.501 1,02 5,00 37.707 3.752.205
2023-02-01 2023-01-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 176.730 927.231 23,55 5,00 883.403 4.634.857
2023-02-01 2023-01-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.542 750.501 1,02 5,00 37.707 3.752.205
2023-01-25 2023-01-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9.900 742.959 1,35 5,00 49.494 3.714.349
2023-01-25 2023-01-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9.900 742.959 1,35 5,00 49.494 3.714.349
2023-01-25 2023-01-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9.900 742.959 1,35 5,00 49.494 3.714.349
2023-01-23 2023-01-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 500 733.059 0,07 5,00 2.498 3.662.363
2023-01-23 2023-01-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.639 732.559 5,42 5,00 188.105 3.661.037
2023-01-23 2023-01-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 500 733.059 0,07 5,00 2.498 3.662.363
2023-01-23 2023-01-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.639 732.559 5,42 5,00 188.105 3.661.037
2023-01-23 2023-01-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 500 733.059 0,07 5,00 2.498 3.662.363
2023-01-23 2023-01-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.639 732.559 5,42 5,00 188.105 3.661.037
2023-01-17 2023-01-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.378 694.920 0,78 4,95 26.603 3.437.491
2023-01-17 2023-01-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.378 694.920 0,78 4,95 26.603 3.437.491
2023-01-17 2023-01-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.378 694.920 0,78 4,95 26.603 3.437.491
2023-01-12 2023-01-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 209.000 689.542 43,49 4,76 994.840 3.282.220
2023-01-12 2023-01-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100.070 480.542 26,30 4,84 484.519 2.326.688
2023-01-12 2023-01-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 209.000 689.542 43,49 4,76 994.840 3.282.220
2023-01-12 2023-01-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100.070 480.542 26,30 4,84 484.519 2.326.688
2023-01-12 2023-01-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 209.000 689.542 43,49 4,76 994.840 3.282.220
2023-01-12 2023-01-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100.070 480.542 26,30 4,84 484.519 2.326.688
2022-12-14 2022-12-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 300 380.472 0,08 4,98 1.493 1.893.495
2022-12-14 2022-12-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 300 380.472 0,08 4,98 1.493 1.893.495
2022-12-14 2022-12-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 300 380.472 0,08 4,98 1.493 1.893.495
2022-11-23 2022-11-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.330 380.172 1,15 5,00 21.646 1.900.518
2022-11-23 2022-11-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35.997 375.842 10,59 5,00 179.942 1.878.759
2022-11-23 2022-11-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.330 380.172 1,15 5,00 21.646 1.900.518
2022-11-23 2022-11-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35.997 375.842 10,59 5,00 179.942 1.878.759
2022-11-23 2022-11-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.330 380.172 1,15 5,00 21.646 1.900.518
2022-11-23 2022-11-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35.997 375.842 10,59 5,00 179.942 1.878.759
2022-11-07 2022-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35.058 339.845 11,50 4,72 165.320 1.602.573
2022-11-07 2022-11-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 104.090 304.787 51,86 4,99 519.107 1.520.003
2022-11-07 2022-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35.058 339.845 11,50 4,72 165.320 1.602.573
2022-11-07 2022-11-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 104.090 304.787 51,86 4,99 519.107 1.520.003
2022-11-07 2022-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 35.058 339.845 11,50 4,72 165.320 1.602.573
2022-11-07 2022-11-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 104.090 304.787 51,86 4,99 519.107 1.520.003
2022-10-31 2022-10-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 76.877 200.697 62,09 4,86 373.638 975.428
2022-10-31 2022-10-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 76.877 200.697 62,09 4,86 373.638 975.428
2022-10-31 2022-10-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 76.877 200.697 62,09 4,86 373.638 975.428
2022-10-27 2022-10-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 72.774 123.820 142,57 4,85 353.041 600.676
2022-10-27 2022-10-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 51.046 51.046 4,75 242.387 242.387
2022-10-27 2022-10-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 72.774 123.820 142,57 4,85 353.041 600.676
2022-10-27 2022-10-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 51.046 51.046 4,75 242.387 242.387
2022-10-27 2022-10-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 72.774 123.820 142,57 4,85 353.041 600.676
2022-10-27 2022-10-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 51.046 51.046 4,75 242.387 242.387
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32.477 90.442 56,03 13,50 438.440 1.220.967
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 951.684 2.650.177 56,03 13,50 12.847.734 35.777.390
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32.477 90.442 56,03 13,50 438.440 1.220.967
2022-06-13 2022-06-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 951.684 2.650.177 56,03 13,50 12.847.734 35.777.390
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.129 57.965 1,99 13,03 14.715 755.475
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.071 1.698.493 1,99 13,03 431.024 22.136.969
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.129 57.965 1,99 13,03 14.715 755.475
2022-06-06 2022-06-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.071 1.698.493 1,99 13,03 431.024 22.136.969
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.036 56.836 5,64 13,45 40.834 764.444
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88.964 1.665.422 5,64 13,45 1.196.566 22.399.926
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.040 53.800 3,94 13,47 27.470 724.460
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 59.766 1.576.458 3,94 13,47 804.797 21.228.268
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.036 56.836 5,64 13,45 40.834 764.444
2022-06-02 2022-06-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88.964 1.665.422 5,64 13,45 1.196.566 22.399.926
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.040 53.800 3,94 13,47 27.470 724.460
2022-06-02 2022-05-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 59.766 1.576.458 3,94 13,47 804.797 21.228.268
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 89 51.760 0,17 13,45 1.197 696.239
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.621 1.516.692 0,17 13,45 35.256 20.401.479
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 667 51.671 1,31 13,49 9.000 697.223
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.534 1.514.071 1,31 13,49 263.582 20.430.117
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 89 51.760 0,17 13,45 1.197 696.239
2022-05-31 2022-05-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.621 1.516.692 0,17 13,45 35.256 20.401.479
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 667 51.671 1,31 13,49 9.000 697.223
2022-05-31 2022-05-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.534 1.514.071 1,31 13,49 263.582 20.430.117
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.429 51.004 2,88 13,43 19.198 685.234
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 41.863 1.494.537 2,88 13,43 562.425 20.078.955
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 588 49.575 1,20 13,37 7.860 662.719
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.240 1.452.674 1,20 13,37 230.464 19.419.346
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.429 51.004 2,88 13,43 19.198 685.234
2022-05-26 2022-05-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 41.863 1.494.537 2,88 13,43 562.425 20.078.955
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 588 49.575 1,20 13,37 7.860 662.719
2022-05-26 2022-05-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.240 1.452.674 1,20 13,37 230.464 19.419.346
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 628 48.987 1,30 13,48 8.464 660.227
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 18.406 1.435.434 1,30 13,48 248.069 19.346.205
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 682 48.359 1,43 13,25 9.040 640.984
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.984 1.417.028 1,43 13,25 264.882 18.782.281
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 628 48.987 1,30 13,48 8.464 660.227
2022-05-23 2022-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 18.406 1.435.434 1,30 13,48 248.069 19.346.205
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 682 48.359 1,43 13,25 9.040 640.984
2022-05-23 2022-05-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.984 1.417.028 1,43 13,25 264.882 18.782.281
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.067 47.677 4,53 13,20 27.292 629.522
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 60.583 1.397.044 4,53 13,20 799.932 18.446.429
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.939 45.610 6,89 13,42 39.433 611.954
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 86.110 1.336.461 6,89 13,42 1.155.346 17.931.431
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.067 47.677 4,53 13,20 27.292 629.522
2022-05-19 2022-05-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 60.583 1.397.044 4,53 13,20 799.932 18.446.429
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.939 45.610 6,89 13,42 39.433 611.954
2022-05-19 2022-05-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 86.110 1.336.461 6,89 13,42 1.155.346 17.931.431
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.094 42.671 2,63 12,90 14.114 550.520
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32.072 1.250.351 2,63 12,90 413.777 16.131.403
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.269 41.577 11,44
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 125.096 1.218.279 11,44
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.094 42.671 2,63 12,90 14.114 550.520
2022-05-17 2022-05-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 32.072 1.250.351 2,63 12,90 413.777 16.131.403
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.269 41.577 11,44
2022-05-17 2022-05-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 125.096 1.218.279 11,44
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17 37.308 0,05 11,81 201 440.447
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 485 1.093.183 0,04 11,81 5.726 12.905.791
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.728 37.291 7,89 11,62 31.702 433.362
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 79.945 1.092.698 7,89 11,62 929.049 12.698.353
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88 34.563 0,26 11,85 1.043 409.478
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.564 1.012.753 0,25 11,85 30.376 11.998.389
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.657 34.475 8,35 11,23 29.827 387.009
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 77.866 1.010.189 8,35 11,23 874.108 11.340.180
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17 37.308 0,05 11,81 201 440.447
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 485 1.093.183 0,04 11,81 5.726 12.905.791
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.728 37.291 7,89 11,62 31.702 433.362
2022-05-13 2022-05-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 79.945 1.092.698 7,89 11,62 929.049 12.698.353
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 88 34.563 0,26 11,85 1.043 409.478
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.564 1.012.753 0,25 11,85 30.376 11.998.389
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.657 34.475 8,35 11,23 29.827 387.009
2022-05-13 2022-05-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 77.866 1.010.189 8,35 11,23 874.108 11.340.180
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.032 31.818 3,35 11,36 11.727 361.567
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.233 932.323 3,35 11,36 343.556 10.594.546
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.745 30.786 9,79 10,79 29.627 332.270
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 80.430 902.090 9,79 10,79 868.073 9.736.167
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.032 31.818 3,35 11,36 11.727 361.567
2022-05-11 2022-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.233 932.323 3,35 11,36 343.556 10.594.546
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.745 30.786 9,79 10,79 29.627 332.270
2022-05-11 2022-05-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 80.430 902.090 9,79 10,79 868.073 9.736.167
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.791 28.041 239,89
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 579.910 821.660 239,88
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.250 8.250
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 241.750 241.750
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.791 28.041 239,89
2022-01-26 2022-01-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 579.910 821.660 239,88
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.250 8.250
2022-01-26 2022-01-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 241.750 241.750
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 7.752 48.406 19,07
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17.829 139.383 14,67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17.829 139.383 14,67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -49.689 0 -100,00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 49.689 49.689
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -1.000.000 989.000 -50,28
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 30.347 40.654 294,43
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 111.247 121.554 1.079,33
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 105.874 116.181 1.027,20
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -438.338 0 -100,00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 438.338 438.338
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -2.000.000 1.394.333 -58,92
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 7.752 48.406 19,07
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17.829 139.383 14,67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 17.829 139.383 14,67
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -49.689 0 -100,00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 49.689 49.689
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -1.000.000 989.000 -50,28
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 30.347 40.654 294,43
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 111.247 121.554 1.079,33
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 105.874 116.181 1.027,20
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -438.338 0 -100,00
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 10.307 10.307
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other 438.338 438.338
2021-05-07 2021-05-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
J - Other -2.000.000 1.394.333 -58,92
2021-02-19 2021-02-17 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
S - Sale -10.000 99.155 -9,16 36,95 -369.503 3.663.807
2021-02-19 2021-02-17 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
S - Sale -10.000 99.155 -9,16 36,95 -369.503 3.663.807
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -30.107 0 -100,00
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
X - Other 30.107 2.584.957 1,18 1,55 46.666 4.006.683
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -30.107 0 -100,00
2020-12-16 2020-12-14 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
X - Other 30.107 2.584.957 1,18 1,55 46.666 4.006.683
2020-09-03 2020-09-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 27.595 1.827.025 1,53 17,67 487.604 32.283.532
2020-09-03 2020-09-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36.494 1.799.430 2,07 17,64 643.754 31.741.945
2020-09-03 2020-09-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 27.595 1.827.025 1,53 17,67 487.604 32.283.532
2020-09-03 2020-09-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36.494 1.799.430 2,07 17,64 643.754 31.741.945
2020-08-31 2020-08-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 26.135 1.762.936 1,50 17,89 467.555 31.538.925
2020-08-31 2020-08-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36.359 1.736.801 2,14 17,79 646.827 30.897.690
2020-08-31 2020-08-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 26.135 1.762.936 1,50 17,89 467.555 31.538.925
2020-08-31 2020-08-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 36.359 1.736.801 2,14 17,79 646.827 30.897.690
2020-08-25 2020-08-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100 1.700.442 0,01 18,00 1.800 30.607.956
2020-08-25 2020-08-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11.024 1.700.342 0,65 17,96 197.991 30.538.142
2020-08-25 2020-08-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.321 1.689.318 0,44 17,97 131.558 30.357.044
2020-08-25 2020-08-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 100 1.700.442 0,01 18,00 1.800 30.607.956
2020-08-25 2020-08-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11.024 1.700.342 0,65 17,96 197.991 30.538.142
2020-08-25 2020-08-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.321 1.689.318 0,44 17,97 131.558 30.357.044
2020-08-17 2020-08-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6.425 1.681.997 0,38 17,89 114.943 30.090.926
2020-08-17 2020-08-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.993 1.675.572 2,32 17,49 664.498 29.305.754
2020-08-17 2020-08-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.895 1.637.579 1,23 17,89 355.922 29.296.288
2020-08-17 2020-08-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6.425 1.681.997 0,38 17,89 114.943 30.090.926
2020-08-17 2020-08-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.993 1.675.572 2,32 17,49 664.498 29.305.754
2020-08-17 2020-08-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.895 1.637.579 1,23 17,89 355.922 29.296.288
2020-08-03 2020-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 732 1.617.684 0,05 17,99 13.169 29.102.135
2020-08-03 2020-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 732 1.617.684 0,05 17,99 13.169 29.102.135
2020-07-30 2020-07-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.105 1.616.952 0,25 17,99 73.849 29.088.966
2020-07-30 2020-07-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 4.105 1.616.952 0,25 17,99 73.849 29.088.966
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686.274 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686.274 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.989.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.836.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -875.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-1 Preferred Stock
C - Conversion -600.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686.274 686.274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686.274 686.274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1.989.000 1.989.000
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1.836.000 3.394.333 117,82
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 875.000 1.558.333 128,05
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 600.000 683.333 720,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686.274 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series D Preferred Stock
C - Conversion -686.274 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.989.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series B Preferred Stock
C - Conversion -1.836.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-2 Preferred Stock
C - Conversion -875.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Series A-1 Preferred Stock
C - Conversion -600.000 0 -100,00
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686.274 686.274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 686.274 686.274
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1.989.000 1.989.000
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 1.836.000 3.394.333 117,82
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 875.000 1.558.333 128,05
2020-07-29 2020-07-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
C - Conversion 600.000 683.333 720,00
2020-07-28 2020-07-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.834 1.612.847 0,24 17,99 68.974 29.015.118
2020-07-28 2020-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 68.749 1.609.013 4,46 17,93 1.232.670 28.849.603
2020-07-28 2020-07-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.834 1.612.847 0,24 17,99 68.974 29.015.118
2020-07-28 2020-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 68.749 1.609.013 4,46 17,93 1.232.670 28.849.603
2020-07-23 2020-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 193 1.540.264 0,01 18,00 3.474 27.724.752
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -24.000 0 -100,00
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 24.000 44.000 120,00 13,35 320.400 587.400
2020-07-23 2020-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 16.806 16.806
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24.000 24.000
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24.000 24.000
2020-07-23 2020-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 193 1.540.264 0,01 18,00 3.474 27.724.752
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -24.000 0 -100,00
2020-07-23 2020-07-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
M - Exercise 24.000 44.000 120,00 13,35 320.400 587.400
2020-07-23 2020-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 16.806 16.806
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24.000 24.000
2020-07-23 2019-05-15 4 NGM NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 24.000 24.000
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-07-23 3 NRIX Nurix Therapeutics, Inc.
Common Stock
166.666
2020-04-09 2020-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 112.602 1.540.071 7,89 14,95 1.683.400 23.024.061
2020-04-09 2020-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 112.602 1.540.071 7,89 14,95 1.683.400 23.024.061
2020-04-07 2020-04-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 123.728 1.427.469 9,49 14,38 1.779.209 20.527.004
2020-04-07 2020-04-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.587 1.303.741 1,13 12,41 181.025 16.179.426
2020-04-07 2020-04-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 123.728 1.427.469 9,49 14,38 1.779.209 20.527.004
2020-04-07 2020-04-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.587 1.303.741 1,13 12,41 181.025 16.179.426
2020-04-02 2020-04-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.850 1.289.154 1,17 12,40 184.140 15.985.510
2020-04-02 2020-04-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118.067 1.274.304 10,21 12,26 1.447.501 15.622.967
2020-04-02 2020-03-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118.067 1.156.237 11,37 12,53 1.479.380 14.487.650
2020-04-02 2020-04-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.850 1.289.154 1,17 12,40 184.140 15.985.510
2020-04-02 2020-04-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118.067 1.274.304 10,21 12,26 1.447.501 15.622.967
2020-04-02 2020-03-31 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 118.067 1.156.237 11,37 12,53 1.479.380 14.487.650
2020-03-25 2020-03-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.416 1.038.170 0,23 12,49 30.176 12.966.743
2020-03-25 2020-03-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 128.377 1.035.754 14,15 12,22 1.568.767 12.656.914
2020-03-25 2020-03-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 170.387 907.377 23,12 11,63 1.981.601 10.552.795
2020-03-25 2020-03-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.416 1.038.170 0,23 12,49 30.176 12.966.743
2020-03-25 2020-03-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 128.377 1.035.754 14,15 12,22 1.568.767 12.656.914
2020-03-25 2020-03-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 170.387 907.377 23,12 11,63 1.981.601 10.552.795
2020-03-23 2020-03-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 143.082 736.990 24,09 11,77 1.684.075 8.674.372
2020-03-23 2020-03-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 148.464 593.908 33,33 11,59 1.720.698 6.883.394
2020-03-23 2020-03-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 143.082 736.990 24,09 11,77 1.684.075 8.674.372
2020-03-23 2020-03-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 148.464 593.908 33,33 11,59 1.720.698 6.883.394
2020-03-23 2020-03-20 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 5.539 6.051.376 0,09 23,15 128.228 140.089.354
2020-03-23 2020-03-19 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 36.135 6.045.837 0,60 22,38 808.701 135.305.832
2020-03-23 2020-03-20 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 5.539 6.051.376 0,09 23,15 128.228 140.089.354
2020-03-23 2020-03-19 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 36.135 6.045.837 0,60 22,38 808.701 135.305.832
2020-03-06 2020-03-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.307 445.444 1,90 18,00 149.526 8.017.992
2020-03-06 2020-03-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.307 445.444 1,90 18,00 149.526 8.017.992
2020-03-04 2020-03-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9.986 437.137 2,34 17,96 179.349 7.850.981
2020-03-04 2020-03-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 38.758 427.151 9,98 17,99 697.256 7.684.446
2020-03-04 2020-03-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.124 388.393 3,77 17,90 252.820 6.952.235
2020-03-04 2020-03-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 9.986 437.137 2,34 17,96 179.349 7.850.981
2020-03-04 2020-03-03 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 38.758 427.151 9,98 17,99 697.256 7.684.446
2020-03-04 2020-03-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 14.124 388.393 3,77 17,90 252.820 6.952.235
2020-02-28 2020-02-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.800 374.269 11,23 17,91 676.998 6.703.158
2020-02-28 2020-02-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.896 336.469 11,20 17,91 607.077 6.026.160
2020-02-28 2020-02-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.751 302.573 1,26 18,00 67.518 5.446.314
2020-02-28 2020-02-28 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 37.800 374.269 11,23 17,91 676.998 6.703.158
2020-02-28 2020-02-27 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.896 336.469 11,20 17,91 607.077 6.026.160
2020-02-28 2020-02-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.751 302.573 1,26 18,00 67.518 5.446.314
2020-02-10 2020-02-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 44.900 298.822 17,68 15,96 716.604 4.769.199
2020-02-10 2020-02-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 44.900 298.822 17,68 15,96 716.604 4.769.199
2019-11-13 2019-11-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15 253.922 0,01 12,00 180 3.047.064
2019-11-13 2019-11-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15 253.922 0,01 12,00 180 3.047.064
2019-11-06 2019-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.409 253.907 3,43 11,99 100.824 3.044.345
2019-11-06 2019-11-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.409 253.907 3,43 11,99 100.824 3.044.345
2019-10-24 2019-10-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.087 245.498 0,86 11,86 24.752 2.911.606
2019-10-24 2019-10-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.300 243.411 0,95 12,00 27.600 2.920.932
2019-10-24 2019-10-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.087 245.498 0,86 11,86 24.752 2.911.606
2019-10-24 2019-10-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.300 243.411 0,95 12,00 27.600 2.920.932
2019-10-21 2019-10-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 43.400 241.111 21,95 11,94 518.196 2.878.865
2019-10-21 2019-10-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.721 197.711 21,30 11,29 392.000 2.232.157
2019-10-21 2019-10-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6.818 162.990 4,37 10,62 72.407 1.730.954
2019-10-21 2019-10-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 43.400 241.111 21,95 11,94 518.196 2.878.865
2019-10-21 2019-10-18 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.721 197.711 21,30 11,29 392.000 2.232.157
2019-10-21 2019-10-17 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6.818 162.990 4,37 10,62 72.407 1.730.954
2019-10-16 2019-10-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.900 156.172 28,78 10,26 358.074 1.602.325
2019-10-16 2019-10-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.200 121.272 37,70 10,31 342.292 1.250.314
2019-10-16 2019-10-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.900 88.072 65,64 10,36 361.564 912.426
2019-10-16 2019-10-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.900 156.172 28,78 10,26 358.074 1.602.325
2019-10-16 2019-10-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 33.200 121.272 37,70 10,31 342.292 1.250.314
2019-10-16 2019-10-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 34.900 88.072 65,64 10,36 361.564 912.426
2019-10-11 2019-10-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 53.172 50,00 10,57 187.343 562.028
2019-10-11 2019-10-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 35.448 100,00 10,50 186.102 372.204
2019-10-11 2019-10-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 17.724 10,26 181.848 181.848
2019-10-11 2019-10-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 53.172 50,00 10,57 187.343 562.028
2019-10-11 2019-10-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 35.448 100,00 10,50 186.102 372.204
2019-10-11 2019-10-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.724 17.724 10,26 181.848 181.848
2019-10-07 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 80.000 159.155 101,07 8,50 680.000 1.352.818
2019-10-07 2019-10-03 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
P - Purchase 1.331.764 6.009.702 28,47 8,50 11.319.994 51.082.467
2019-08-09 2019-08-09 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 152 2.597.816 0,01 13,99 2.126 36.343.446
2019-08-09 2019-08-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12 2.597.664 0,00 13,98 168 36.315.343
2019-08-09 2019-08-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 224.500 2.597.652 9,46 14,00 3.143.000 36.367.128
2019-08-07 2019-08-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 310 2.373.152 0,01 13,96 4.328 33.129.202
2019-08-07 2019-08-05 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 5.824 2.372.842 0,25 13,98 81.400 33.164.263
2019-08-05 2019-08-02 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.782 2.367.018 0,08 13,97 24.898 33.072.212
2019-08-05 2019-08-01 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 2.600 2.365.236 0,11 13,98 36.346 33.064.107
2019-07-31 2019-07-30 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 8.855 2.362.636 0,38 13,91 123.195 32.870.173
2019-07-31 2019-07-29 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 19.201 2.353.781 0,82 13,58 260.727 31.961.521
2019-07-26 2019-07-26 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.059 2.334.580 1,30 13,59 408.634 31.737.214
2019-07-26 2019-07-25 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.753 2.304.521 1,35 13,37 411.294 30.820.894
2019-07-26 2019-07-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 29.054 2.273.768 1,29 13,51 392.502 30.717.241
2019-07-23 2019-07-23 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.760 2.244.714 1,39 13,35 410.535 29.958.851
2019-07-23 2019-07-22 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 30.760 2.213.954 1,41 13,54 416.337 29.965.867
2019-07-23 2019-07-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 6.222 2.183.194 0,29 13,99 87.043 30.541.792
2019-07-17 2019-07-16 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.900 2.176.972 0,18 13,86 54.055 30.173.485
2019-07-17 2019-07-15 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 16.188 2.173.072 0,75 13,69 221.547 29.740.446
2019-07-15 2019-07-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 21.014 2.156.884 0,98 13,88 291.765 29.946.825
2019-07-15 2019-07-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10.870 2.135.870 0,51 13,87 150.752 29.621.527
2019-06-26 2019-06-24 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12.240 2.125.000 0,58 13,78 168.650 29.279.525
2019-06-21 2019-06-21 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 3.763 2.112.760 0,18 14,03 52.789 29.638.854
2019-06-21 2019-06-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15.400 2.108.997 0,74 13,86 213.385 29.222.684
2019-06-21 2019-06-19 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15.214 2.093.597 0,73 13,91 211.674 29.128.424
2019-06-14 2019-06-14 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10.760 2.078.383 0,52 14,00 150.687 29.106.507
2019-06-14 2019-06-13 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 11.500 2.067.623 0,56 14,13 162.508 29.217.787
2019-06-14 2019-06-12 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 7.500 2.056.123 0,37 14,00 104.989 28.782.638
2019-06-11 2019-06-11 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 10.900 2.048.623 0,53 13,83 150.718 28.326.925
2019-06-11 2019-06-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12.600 2.037.723 0,62 13,66 172.176 27.845.077
2019-06-06 2019-06-06 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12.600 2.025.123 0,63 13,40 168.884 27.143.736
2019-06-06 2019-06-04 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 12.600 2.012.523 0,63 13,39 168.764 26.955.733
2019-05-22 2019-05-20 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 50.000 1.999.923 2,56 13,50 675.000 26.998.960
2019-05-13 2019-05-10 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 17.923 1.949.923 0,93 13,85 248.234 27.006.434
2019-05-09 2019-05-07 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 57.000 1.932.000 3,04 14,10 803.700 27.241.200
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -3.400.000 0 -100,00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series C Preferred Stock
C - Conversion -2.377.334 0 -100,00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -8.408.933 0 -100,00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -12.000.000 0 -100,00
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 15.000 15.000 16,00 240.000 240.000
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
P - Purchase 1.875.000 1.875.000 16,00 30.000.000 30.000.000
2019-04-10 2019-04-08 4 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
C - Conversion 13.093.134 13.569.091 2.750,91
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951.914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951.914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951.914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951.914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951.914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951.914
2019-04-03 3 NGM NGM BIOPHARMACEUTICALS INC
Common Stock
951.914
2019-04-02 2019-04-02 4 IMDZ IMMUNE DESIGN CORP.
Common Stock
U - Other -6.642.942 0 -100,00 5,85 -38.861.211
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
C - Conversion -300.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series F Preferred Stock
C - Conversion -20.000.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E-1 Preferred Stock
C - Conversion -6.502.856 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
C - Conversion -444.444 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series E Preferred Stock
C - Conversion -3.555.555 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series D Preferred Stock
C - Conversion -970.159 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series B Preferred Stock
C - Conversion -8.333.333 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Series A Preferred Stock
C - Conversion -11.000.000 0 -100,00
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
C - Conversion 79.155 79.155
2018-07-23 2018-07-23 4 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
C - Conversion 4.666.888 4.677.939 42.230,46
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2018-07-18 3 CNST CONSTELLATION PHARMACEUTICALS INC
Common Stock
22.102
2017-10-30 2017-10-27 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 2.681.000 6.642.942 67,67 4,10 10.992.100 27.236.062
2016-09-22 2016-09-20 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 800.000 3.961.942 25,30 6,25 5.000.000 24.762.138
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -428.134 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
X - Other 428.134 428.134
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock Warrant (right to buy)
X - Other -428.134 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series C Preferred Stock
C - Conversion -856.269 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series B Preferred Stock
C - Conversion -744.580 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Series A Preferred Stock
C - Conversion -733.943 0 -100,00
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
P - Purchase 399.016 3.161.942 14,44 12,00 4.788.192 37.943.304
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 428.134 2.762.926 18,34
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 856.269 2.334.792 57,91
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 744.580 1.478.523 101,45
2014-07-31 2014-07-29 4 IMDZ Immune Design Corp.
Common Stock
C - Conversion 733.943 733.943
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)